Health insurance CEOs appear before Congress, blame high cost of health care on hospitals, doctors, and prescription drugs.
Over 60 health systems called on national health record exchanges to take action to prevent “bad actors” from accessing patients’ health information.
A new FDA pathway meant to enable one-time gene-editing cures is welcomed in theory but could, ethicists warn, become a Pandora's box.
Evidence for universally adopted cancer treatment guidelines is incomplete when trial participants aren't representative.
